- Filed
- May 9, 2022 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2022 · May 2, 2022 | 132.8M sh |
| Cash And Equivalents | Q1 2022 · Mar 31, 2022 | $97.41M |
| Cash And Equivalents | Q1 2022 · Dec 31, 2021 | $132.89M |
| Total Liabilities | Q1 2022 · Mar 31, 2022 | $123.63M |
| Total Liabilities | Q1 2022 · Dec 31, 2021 | $122.69M |
| Total Assets | Q1 2022 · Mar 31, 2022 | $1.26B |
| Total Assets | Q1 2022 · Dec 31, 2021 | $1.27B |
| Shares Diluted | Q1 2022 · Mar 31, 2021 | 132.68M sh |
| Capex | Q1 2022 · Mar 31, 2021 | $135K |
| Operating Cash Flow | Q1 2022 · Mar 31, 2021 | $16.34M |
| Stockholders Equity | Q1 2022 · Mar 31, 2021 | $1.17B |
| Stockholders Equity | Q1 2022 · Dec 31, 2020 | $1.17B |
| Eps Diluted | Q1 2022 · Mar 31, 2021 | $0.15 |
| Eps Basic | Q1 2022 · Mar 31, 2021 | $0.15 |
| Sga Expense restated | Q1 2022 · Mar 31, 2021 | $2.65M |
| Net Income | Q1 2022 · Mar 31, 2021 | $20.38M |